MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • White Papers
  • DeviceTalks
Home » GI Dynamics raises $2m

GI Dynamics raises $2m

January 23, 2018 By Fink Densford Leave a Comment

Share

GI DynamicsGI Dynamics (ASX:GID) said yesterday it raised approximately $1.6 million (AUD $2 million) in a private placement of Australian CHESS depository interests looking to support continued development of its EndoBarrier and for general working capital.

The Boston-based company said the placement comes through the sale of approximately 58.8 million CDIs, representing 1.2 million shares of common stock at 28¢ (AUD 35¢) per share in two tranches.

The first tranche, which closed today, consists of 28.5 million CDIs, representing 569,341 shares of common stock and raising $779,442 (AUD $996,347), GI Dynamics said.

The second tranche is expected to consist of 30.3 million CDIs, representing 606,271 shares of common stock expected to raise $830,000 (AUD $1.1 million).

“We are focused on securing approval for a study from the FDA for a new pivotal clinical trial of EndoBarrier. The leadership team, employees, and directors of GI Dynamics remain resolved in our commitment to continue to develop EndoBarrier for the millions of patients who have no viable treatment option for type 2 diabetes and obesity,” prez & CEO Scott Schorer said in a press release.

In its offering release, GI Dynamics said it “continues to operate with substantial doubt about its ability to continue as a going concern.”

Last November, GI Dynamics said its notified body in Europe withdrew its certification for CE Mark approval for its EndoBarrier device, meaning the company can no longer sell the obesity and diabetes treatment in the European Union.

Filed Under: Business/Financial News, Wall Street Beat Tagged With: GI Dynamics

In case you missed it

  • Leaf Healthcare touts reduced pressure injuries in Leaf wearable sensor study
  • Masimo touts ORi obese patient arterial hemoglobin desaturation warning study results
  • Bracco Imaging explores using microbubbles to deliver personalized gene therapy
  • Nemaura uplists shares to NASDAQ exchange
  • Whistleblower allegations cause Obalon to spike $35m offering
  • Glytec touts patient outcomes for diabetes management system
  • GI Dynamics raises $2m
  • Lenis inks distribution deal for needle-free injection system
  • ResMed tops Wall Street’s Q2 earnings forecast, despite $127m tax hit
  • Pulmatrix wins EU nod for inhaled dry-powder anti-fungal trial
  • Smith & Nephew updates on corporate tax adjustments
  • Johnson & Johnson logs Q4 beat, misses with 2017 numbers
  • Neovasc taps former Boston Scientific CRM vet Colen for CEO | Personnel Moves January 22, 2018
  • Topcon’s ocular diagnostic instrument lands 510(k) clearance
  • UPDATE: Senate, Congress vote to end federal shutdown, pause medical device tax
  • Adhesys Medical wins CE Mark for Flix surgical adhesive
  • Gottlieb: Shutdown means furloughs for 42% of FDA staff

RSS From Medical Design & Outsourcing

  • What should really trigger a CAPA?
    When should a problem with a medical device trigger a CAPA (Corrective Action and Preventative Action)? Jon Speer at Greenlight Guru has some thoughts.  Jon Speer, Greenlight Guru After years of working with medical device companies, we’ve found that there is a particular area that is often rife with issues for companies: CAPA (Corrective Action and Preventative Action). […]
  • 3M submits 510(k) for steam sterilization system
    3M has submitted an application for FDA 510(k) clearance for its Attest Super Rapid System for Steam Sterilization. The steam sterilization system can provide biological indicator results in 24 minutes. A faster readout time for steam will help improve patient safety while increasing workflow for sterilization professionals. “The focus of our sterilization science at 3M […]
  • Guill Tool opens in-house rheology lab
    Guill Tool has launched its in-house rheology laboratory to minimize the time between testing and production. The company built its rheology lab in its West Warwick, R.I. facility. The lab has several machines that help produce optimum results when testing new materials that need to be extruded. The equipment is a hybrid rotational rheometer, a […]
  • NSF International appoints new executive director of medical device certification and training
    NSF International has appointed FDA veteran Robert Ruff to the role of executive director of medical device certification and training. Ruff will offer expert training and certification services to NSF International’s medical device industry clients. He will be responsible for managing key sectors of the company’s medical device business. “Rob brings the utmost integrity and […]
  • Qosina expands stopcocks line
    Qosina recently announced that it has added 12 new stopcocks to its line of bulk and non-sterile components. The new stopcocks are designed to be REACH and RoHS compliant with low profiles and low pressure ratings. They also feature unique configurations like build-in styles. Qosina offers 100 options of the stopcocks and supplies one-way, two-way, […]
  • These medtech companies raised the most VC last year
    Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving […]
  • Medtech stories we missed this week: Jan. 19, 2018
    From Privi Medical’s FDA clearance to OrthoXel getting FDA clearance and CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Privi Medical wins FDA nod for hemorrhoid device Privi Medical has received FDA clearance for its Instalief Hemorrhoids Treatment device, according to a Jan. 18 news […]
  • How blockchains could empower patients and secure data
    Blockchains are best known as the technology behind cryptocurrencies such as Bitcoin. But the founders of a young Atlanta-based company called Patientory think they could have another important use – securing health data and empowering patients along the way. Secure access to patient data is a major issue for the healthcare industry. Patients have a […]
  • Phillips-Medisize’s increased business to benefit Molex plant in Arkansas
    Phillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark. Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader […]
  • GlobTek touts EAC-certified off-the-shelf power supplies for medical, other applications
    GlobTek is touting the wide variety of EAC-certified power supplies that it is offering for applications including medical, information technology equipment, household and more. A full list is available on the Northvale, N.J.–based company’s website.  EAC certification, formerly known as the Russian GOST-R certification, implements a new logo (EAC mark)  – and involves the implementation […]
  • Robotic spine surgery is getting a real-time image guide boost
    For the first time, surgeons at Johns Hopkins Hospital were able to harness real-time image guidance during a robotic spine surgery procedure to insert screws into a patient’s spine. The process offers a marked improvement over the accuracy of placement compared with other image-guided procedures. Dr. Nicholas Theodore – professor of neurosurgery at the Johns Hopkins University […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Connect with us on Google PlusGoogle+

Copyright © 2018 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy